Canada has authorized the use of the booster dose of the Covid vaccine co-developed by Pfizer and BioNTech for those aged 18 years and above.
The decision from the Canadian health authorities makes Pfizer/BioNTech’s application for its booster the first to get clearance in Canada on Tuesday.
The booster, according to Health Canada, can be administered to those who completed the full “primary series” of two doses at least six months earlier.
“Booster doses are designed to help people maintain their immunity longer. Health Canada authorized the booster dose after a thorough, independent review of the evidence,” Health Canada said in a tweet.
Last month, the National Advisory Committee on Immunization (NACI) recommended that those at risk, including seniors above 70, could be given a booster of a Covid vaccine, while also stating it could be given to those who had two doses of the Astra Zeneca jab.
Source: The Hindustan Times
BDST: 1658 HRS, NOV 10, 2021